Biology subjects

Maliekal, T. T.

Publications and source records attributed to Maliekal, T. T..

4 recordsLinked to original sources

bioRxiv2025

TIF1γ drives oral cancer recurrence by the transcriptional regulation of self-renewal genes, such as HES1

TIF1{gamma} is an E3 ubiquitin ligase and key mediator of the noncanonical TGF-{beta} signaling pathway. Initially characterized for its developmental functions, TIF1{gamma} is essential for maintaining the pluripotency of adult stem cells, including long-term hematopoietic stem cells. Although TGF-{beta} signaling contributes to cancer progression and recurrence, TIF1{gamma} has traditionally been regarded as a tumor suppressor due to its inhibition of oncogenes involved in epithelial-mesenchymal transition. However, clinical reports have associated high TIF1{gamma} expression at advanced cancer stages with poor prognosis. To elucidate the mechanism underlying this paradox, we identify a previously unrecognized role of TIF1{gamma} in promoting the self-renewal capacity of oral cancer cells, thereby contributing to disease recurrence. Phosphoproteomic profiling of self-renewal-enriched cells revealed activation of a noncanonical TGF-{beta} pathway. Using extreme limiting dilution assays, an ALDH1A1-DsRed2 cancer stem cell reporter, multiple oral cancer cell lines, primary 3D cultures on alginate matrix, and orthotopic mouse models, we demonstrate that TIF1{gamma} depletion significantly reduces self-renewal and prolongs disease-free survival. Immunoprecipitation (IP)-LC/MS/MS analysis identified transcriptional regulators within the TIF1{gamma} interactome, including TRRAP and H2A.Z, which were validated by IP and FRET assays. ChIP and IP studies further revealed that during self-renewal enrichment, TRRAP acetylates H2A.Z, decreasing the chromatin occupancy of its unacetylated form. Acetylated H2A.Z is subsequently recognized by TIF1{gamma}, which monoubiquitinates H2B at promoters of self-renewal genes such as HES1, initiating transcription. In alignment with findings from mouse neocortical development, where a Notch-independent Hes1-expressing (NIHes1) population defines primitive quiescent stem cells, we show that TIF1{gamma} acts as an acetylation reader specifically at the NIHES1 promoter region of HES1. TIF1{gamma} depletion drives NIHES1 cells toward a Notch-dependent HES1 (NDHES1) identity. RNA-seq confirmed reversal of 100 NIHES1-specific genes following TIF1{gamma} loss, along with downregulation of pluripotency-associated genes found in embryonic stem cells, supporting a critical role for TIF1{gamma} in maintaining primitive cancer stem cell states. Consistent with our in vivo findings, primary oral cancer samples showed that increased frequencies of TIF1{gamma}+/TRRAP+/H2A.Z- cells strongly predict recurrence. Given that the histone acetylation-reader function of TIF1{gamma} drives poor prognosis, our findings suggest the TIF1{gamma} bromodomain as a potential therapeutic target requiring further investigation.

cancer biology↗

bioRxiv2025

EPHA2-dependent Ephrin-B1 signaling supports self-renewal ability and recurrence of oral cancer

Eph-Ephrin pathway that drives a bidirectional signaling regulates a plethora of biological activities with its varied level of complexity. While the canonical trans-interaction of the ligand and receptor on neighboring cells initiates forward signaling that brings about biological activities, their cis-interaction on the same cell attenuates the forward signaling, modulating the biological effects. Yet, non-canonical cis-interactions with heterotypic surface proteins and kinases regulate certain biological effects. In cancer, the canonical signaling is believed to be tumor suppressive, while the ligand-independent non-canonical signaling drives tumor progression and poor prognosis. Self-renewal ability of cancer cells is a major underlying cause of recurrence and poor prognosis of cancer. Using SILAC-based proteomics, we identified Ephrin-B1 signaling as a crucial regulator of oral cancer self-renewal. Though Ephrin-B1 is known to regulate normal stem cells, its role in cancer remains underexplored. Our biochemical analyses show that Ephrin-B1 binds to a nonconventional receptor EPHA2, which is known to regulate cancer stem cells (CSCs), though the mechanism is less explored. Contrary to the belief that the cis-interaction of receptors and ligands is a means to block functional signaling, our immunoprecipitation, FRET facilitated photoswitching analysis, proximity ligation assay, and in vitro kinase assay provide evidence for the Ephrin-B1-EPHA2 cis-interaction leading to the phosphorylation of EphrinB1 at Y324/329 and Y317. Extreme limiting dilution assay in vitro and in vivo confirmed that this cis-interaction promotes CSC enrichment. Substantiating our in vitro results, mouse orthotopic models showed that Ephrin-B1/EPHA2 interaction regulates prognosis. The clinical relevance of the finding was validated using a TCGA data set and immunohistochemical analysis of tissue microarray using samples from oral cancer patients with recurrence in comparison to patients, who showed disease-free survival. Given that Ephrin-B interacts with EphB for normal stem cell homeostasis, this unconventional EPHA2/Ephrin-B1 cis-interaction, specifically manifested in CSC niches, might serve as an attractive target for therapy, warranting further validation.

cancer biology↗

bioRxiv2022

Acquisition of hybrid E/M phenotype associated with increased migration, drug resistance and stemness is mediated by reduced miR-18a levels in ER-negative breast cancer

The complexity of the ER-negative subtype of breast cancer arises due to the heterogeneous nature of the disease rendering them more aggressive and this poses a challenge to effective treatment and eventually the prognosis of the patients. We have explored the miRNA regulation of altered molecular signatures and the effect on tumour progression in ER-negative breast cancer. Using breast tumour specimens, gene expression data from public datasets and in-vitro and in-vivo model systems we have shown that low-levels of miR-18a in ER-negative tumours drives enrichment of hybrid Epithelial/Mesenchymal (E/M) cells with luminal attributes. On inhibition of miR-18a in ER-negative breast cancer cell lines, the cells showed traits of increased migration, stemness and drug-resistance. miR-18a/low tumours were also associated with increased expression of genes associated with EMT, stemness, drug resistance and immune-suppression. Further analysis of the miR-18a targets pointed out at a possible HIF-1 mediated signalling in these tumours. HIF-1 inhibition reduced the enrichment of the hybrid E/M cells and decreased the migratory ability of miR-18a/low cells. Our study reports for the first time a dual role of miR-18a in breast cancer that is subtype specific based on hormone receptor expression and a novel association of low miR-18a levels and enrichment of hybrid E/M cells. The results highlight the possibility of stratifying the ER-negative disease into clinically relevant groups by analysing epigenetic signatures.

cancer biology↗

bioRxiv2019

Histone chaperone Nucleophosmin regulates transcription of key genes involved in oral tumorigenesis.

Nucleophosmin (NPM1) is a multifunctional histone chaperone that can activate RNA Polymerase II-driven chromatin transcription. Acetylation of NPM1 by acetyltransferase p300 has been shown to further enhance its transcription activation potential. Moreover, its total and acetylated pools are increased in oral squamous cell carcinoma. However, the role of NPM1 or its acetylated form (AcNPM1) in transcriptional regulation in cells is not fully elucidated. Using ChIP-seq analyses, we show that AcNPM1 co-occupies marks of active transcription at promoters and DNase I hypersensitive sites at enhancers. Moreover, NPM1 interacts with proteins involved in transcription, including RNA Pol II, general transcription factors, mediator subunits, histone acetyltransferase complexes, and chromatin remodelers. Moreover, its histone chaperone also contributes to transcriptional activation. We further show that AcNPM1 regulates key genes required for proliferation, migration and invasion potential of oral cancer cells and knockdown of NPM1 mitigates these processes in cells as well as orthotopic tumors in mice. Collectively, these results establish that AcNPM1 functions as a coactivator and regulates the expression of key genes involved in oral tumorigenesis.

biochemistry↗